**Core Concept:**
Clonidine is a sympatholytic drug that acts as a selective α2-adrenergic receptor agonist. It is primarily used as an anti-hypertensive agent by decreasing sympathetic nervous system activity, thus reducing heart rate and blood pressure.

**Why the Correct Answer is Right:**
When clonidine is administered intravenously at a rapid rate, its effect on α2-adrenergic receptors is dissipated quickly. This rapid dissipation leads to a sudden drop in clonidine's concentration in the bloodstream. As a result, the sympathetic nervous system is not adequately suppressed, causing an increased heart rate and subsequently higher blood pressure.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Increased α1-adrenergic activity):** Clonidine is a selective α2-adrenergic receptor agonist, not an α1-adrenergic receptor antagonist. Rapid intravenous administration does not cause increased α1-adrenergic activity, which would lead to vasoconstriction and further elevate blood pressure.

B. **Option B (Increased heart rate):** While clonidine does decrease heart rate initially, rapid intravenous administration allows its rapid dissipation, leading to a sudden increase in heart rate and blood pressure.

C. **Option C (Increased sympathetic nervous system activity):** Clonidine reduces sympathetic nervous system activity, not increases it. Rapid intravenous administration disrupts the gradual activation of α2-adrenergic receptors, resulting in higher blood pressure.

D. **Option D (Decreased baroreceptor sensitivity):** Clonidine increases baroreceptor sensitivity by activating α2-adrenergic receptors, reducing sympathetic outflow and blood pressure. Rapid intravenous administration disrupts this mechanism, leading to increased blood pressure.

**Clinical Pearl:**
When using clonidine as an antihypertensive agent, the rate of administration should be slow to ensure effective and sustained suppression of sympathetic nervous system activity, leading to a decrease in blood pressure. Rapid administration, as in Option A, C, and D, can result in the adverse effect described in the question.

In conclusion, administering clonidine via intravenous infusion at a slow rate is essential to achieve its intended antihypertensive effect. Rapid administration, as in the incorrect options, results in the described unfavorable outcome.